As of 2024-12-12, the Intrinsic Value of Algernon Pharmaceuticals Inc (AGN.CN) is
-0.59 CAD. This AGN.CN valuation is based on the model Peter Lynch Fair Value.
With the current market price of 0.07 CAD, the upside of Algernon Pharmaceuticals Inc is
-949.01%.
Note: result may not be accurate due to the invalid valuation result of Peter Lynch's fair value model.
-0.59 CAD
Intrinsic Value
AGN.CN Intrinsic Value - Valuation Summary
|
Range |
Selected |
Upside |
| a |
| Fair Value |
-0.59 - -0.59 |
-0.59 |
-949.01% |
| P/E |
(0.00) - (0.01) |
(0.01) |
-108.5% |
| DDM - Stable |
(2.37) - 10.34 |
3.98 |
5591.3% |
| DDM - Multi |
(6.28) - 21.42 |
(17.88) |
-25647.4% |
AGN.CN Intrinsic Value - Key Valuation Metrics
| Market Cap (mil) |
1.54 |
| Beta |
0.52 |
| Outstanding shares (mil) |
21.94 |
| Enterprise Value (mil) |
1.46 |
| Market risk premium |
5.10% |
| Cost of Equity |
5.24% |
| Cost of Debt |
5.00% |
| WACC |
4.46% |